Q32 Bio Inc.

SEC 4 · Filed

0001193125-26-032247Accepted

Applies to the EDGAR acceptance time.

Other time zone
Insider transactionsEvent date Jan 15, 2026

Grant, award or other acquisition by GRAYZEL DAVID S.

Security
Stock Option (Right to Buy)
Code
A
Shares
16,363
Price per share
2.75
Structured facts
{
  "code": "A",
  "date": "2026-01-15",
  "direction": "A",
  "exercise_price": "3.60",
  "expiration": "2036-01-14",
  "footnotes": {
    "F1": "This option was granted to the Reporting Person, a director of the Issuer pursuant to the 2024 Stock Option and Incentive Plan and pursuant to the Issuer\u0027s non-employee director compensation policy. This option shall vest in four equal quarterly installments as of the last date of each calendar quarter subject to the Reporting Person\u0027s continued service through such date and represents the Reporting Person\u0027s election to receive stock options in lieu of cash retainer fees. Due to administrative oversight this option award initially was not reported.",
    "F2": "This option was granted to the Reporting Person, a director of the Issuer. The proceeds of any sale of shares of common stock issued to the Reporting Person upon exercise of this option will be transferred to Atlas Venture Life Science Advisors, LLC and as such, the Reporting Person disclaims ownership of such securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of his pecuniary interest therein, if any."
  },
  "owners": [
    {
      "cik": "0001732786",
      "name": "GRAYZEL DAVID S.",
      "roles": [
        "director"
      ],
      "title": null
    }
  ],
  "ownership": "D",
  "post_shares": "16363",
  "price": "2.75",
  "row": 1,
  "rule_10b5_1": "false",
  "security": "Stock Option (Right to Buy)",
  "shares": "16363",
  "table": "II",
  "underlying_security": "Common Stock",
  "underlying_shares": "16363"
}